Status:

NOT_YET_RECRUITING

Language Intervention Training for Cognitive Protection in High-risk Cardio-Cerebrovascular Elderly Population

Lead Sponsor:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions:

Vascular Cognitive Impairment No Dementia

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

The global population is aging rapidly, with the number of elderly people with dementia projected to rise sharply, posing significant challenges to quality of life and societal burden.Frequent languag...

Detailed Description

The global population is aging rapidly, with those aged 65+ expected to reach 16% of the total population by 2050. Aging is linked to increased cognitive impairment risks, including dementia prevalenc...

Eligibility Criteria

Inclusion

  • Patients aged ≥ 60 years
  • High risk of stroke (with ≥ 3 of 8 stroke risk factors, including hypertension, dyslipidemia, diabetes, atrial fibrillation or valvular heart disease, smoking history, obvious overweight or obesity, lack of exercise, family history of stroke, or with transient ischemic attack)
  • command of Hangzhou dialect
  • Written informed consent available
  • Willingness to complete all assessments and participate in follow-up
  • Adequate Visual and auditory acuity to undergo neuropsychological testing

Exclusion

  • previously diagnosed dementia
  • Suspected dementia after clinical assessment by study physician at screening visit
  • Previous history of major head trauma and any intracranial surgery
  • Intracranial abnormalities, such as intracerebral hemorrhage, subarachnoid hemorrhage and other space occupying lesions
  • Extrapyramidal symptoms or mental illness which may affect neuropsychological measurement
  • Severe loss of vision, hearing, or communicative ability
  • Patients presenting a malignant disease with life expectancy \< 3 years
  • Participation in an ongoing investigational drug study
  • Any MRI contraindications

Key Trial Info

Start Date :

April 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 20 2026

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06898931

Start Date

April 15 2025

End Date

September 20 2026

Last Update

March 27 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.